LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

Search

AmerisourceBergen Corporation

Закрыт

СекторЗдравоохранение

0

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

Макс.

Ключевые показатели

By Trading Economics

Доход

-1B

-340M

Продажи

3.1B

84B

P/E

Средняя по отрасли

42.387

77.671

Прибыль на акцию

3.84

Дивидендная доходность

0.65

Рентабельность продаж

-0.406

Сотрудники

47,000

EBITDA

-1.1B

150M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+16.93% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

0.65%

2.35%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-564M

66B

Предыдущая цена открытия

0

Предыдущая цена закрытия

0

Новостные настроения

By Acuity

5%

95%

3 / 374 Рейтинг в Healthcare

AmerisourceBergen Corporation График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 дек. 2025 г., 22:02 UTC

Отчет

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 дек. 2025 г., 21:46 UTC

Отчет

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 дек. 2025 г., 23:52 UTC

Приобретения, слияния, поглощения

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 дек. 2025 г., 23:43 UTC

Обсуждения рынка

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 дек. 2025 г., 23:36 UTC

Обсуждения рынка

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 дек. 2025 г., 23:20 UTC

Отчет

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 дек. 2025 г., 23:15 UTC

Отчет

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 дек. 2025 г., 22:59 UTC

Обсуждения рынка
Отчет
Приобретения, слияния, поглощения

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 дек. 2025 г., 22:45 UTC

Обсуждения рынка

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 дек. 2025 г., 22:40 UTC

Отчет

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 дек. 2025 г., 22:06 UTC

Приобретения, слияния, поглощения

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 дек. 2025 г., 22:06 UTC

Отчет

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 дек. 2025 г., 22:02 UTC

Отчет

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 дек. 2025 г., 22:00 UTC

Отчет

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 дек. 2025 г., 21:53 UTC

Отчет

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 дек. 2025 г., 21:50 UTC

Приобретения, слияния, поглощения

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 дек. 2025 г., 21:50 UTC

Обсуждения рынка
Отчет
Приобретения, слияния, поглощения

Financial Services Roundup: Market Talk

10 дек. 2025 г., 21:50 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

10 дек. 2025 г., 21:50 UTC

Обсуждения рынка

Auto & Transport Roundup: Market Talk

10 дек. 2025 г., 21:45 UTC

Приобретения, слияния, поглощения

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 дек. 2025 г., 21:33 UTC

Отчет

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 дек. 2025 г., 21:32 UTC

Отчет

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 дек. 2025 г., 21:28 UTC

Приобретения, слияния, поглощения

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 дек. 2025 г., 21:25 UTC

Отчет

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 дек. 2025 г., 21:18 UTC

Приобретения, слияния, поглощения

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 дек. 2025 г., 21:16 UTC

Отчет

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 дек. 2025 г., 21:15 UTC

Приобретения, слияния, поглощения

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 дек. 2025 г., 21:15 UTC

Отчет

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 дек. 2025 г., 21:14 UTC

Отчет

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 дек. 2025 г., 21:14 UTC

Отчет

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Сравнение c конкурентами

Изменение цены

AmerisourceBergen Corporation Прогноз

Целевая цена

By TipRanks

16.93% рост

Прогноз на 12 месяцев

Средняя 394.4 USD  16.93%

Максимум 417 USD

Минимум 361 USD

Основано на мнении 11 аналитиков Wall Street, спрогнозировавших целевые цены для AmerisourceBergen Corporation на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

11 ratings

10

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

3 / 374Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat